2-47800166-A-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_000179.3(MSH6):āc.2183A>Gā(p.Lys728Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000041 in 1,461,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000179.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250944Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135614
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461862Hom.: 0 Cov.: 34 AF XY: 0.00000413 AC XY: 3AN XY: 727226
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:3Benign:1
- -
This missense variant replaces lysine with arginine at codon 728 of the MSH6 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with rectal cancer (PMID: 25559809). This variant has been identified in 3/250944 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
c.2183A>G, located in exon 4 of the MSH6 gene, is predicted to result in the substitution of lysine by arginine at codon 728, p.(Lys728Arg). This variant is found in 6/1614212 alleles at a frequency of 0,0003% in the gnomAD v4 database (PM2_Supporting). Computational tools for this variant suggest no significant impact on protein function (MAPP+PolyPhen-2 prior probability for pathogenicity: 0.0006) and the SpliceAI algorithm predicts no significant impact on splicing (BP4). To our knowledge, neither relevant clinical data nor well-established functional studies have been reported for this variant. It has been reported in a colorectal and endometrial cancer-affected patient, whose endometrial tumor showed isolated loss of MSH6 by IHC (PP4). This variant has been reported in the ClinVar database (2x likely benign, 6x uncertain significance), in LOVD (1x unclassified) and has not been classified in the InSiGHT database. Based on currently available information, the variant c.2183A>G should be considered an uncertain significance variant according to ClinGen CRC ACMG Specifications MSH6 v1.0.0. -
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Lynch syndrome Uncertain:2
This missense variant replaces lysine with arginine at codon 728 of the MSH6 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been performed for this variant. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has been identified in 3/250944 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
- -
MSH6-related disorder Uncertain:1
The MSH6 c.2183A>G variant is predicted to result in the amino acid substitution p.Lys728Arg. This variant was reported in an individual with breast and/or ovarian cancer and in an individual with rectal cancer (Molina-Zayas et al. 2022. PubMed ID: 35451682; Chubb D et al. 2015. PubMed ID: 25559809). This variant is reported in 0.0058% of alleles in individuals of Latino descent in gnomAD. This variant has conflicting interpretations in ClinVar from uncertain significance to likely benign (https://www.ncbi.nlm.nih.gov/clinvar/variation/479867/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Endometrial carcinoma;C1833477:Lynch syndrome 5;C5399763:Mismatch repair cancer syndrome 1 Uncertain:1
- -
not provided Uncertain:1
Not observed at a significant frequency in large population cohorts (Lek 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Observed in individuals with colorectal cancer (Chubb 2015); This variant is associated with the following publications: (PMID: 25559809) -
Endometrial carcinoma Uncertain:1
- -
Hereditary nonpolyposis colorectal neoplasms Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at